- Symbol
- BFRI
- Segment MIC
- XNCM
- ISIN
- US09077D2099
- Trading currency
- USD
XNCM:BFRI — listed on NASDAQ CAPITAL MARKET
Biofrontera Inc. is a biopharmaceutical company based in Woburn, Massachusetts, focused on developing and commercializing treatments for dermatological conditions using photodynamic therapy (PDT). The company manages the entire lifecycle of its products, from clinical innovation to commercialization, and holds all relevant patents and regulatory approvals for the U.S. market. Biofrontera Discovery GmbH, its wholly owned subsidiary in Germany, supports its scientific and operational activities, including clinical development and manufacturing.